Company / Operating Income per Share
Revolution Medicines, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$6.36
FY2025
5-year range
-$6.36 / -$0.81
FY2021-FY2025
Trend
-51.9%
vs FY2024
Sector context
#181 of 201
Health Care
What the data says
Among 201 Health Care companies, Revolution Medicines, Inc. is in the bottom 10% for operating income per share. Operating Income per Share has fluctuated over the past 8 years, ranging from $-19.52 in FY2019 to $-0.81 in FY2021.
Based on SEC 10-K filings.
-6.36 in FY2025.
Declined from $-5.39 to $-6.36 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 201This company -$6.36 Sector average -$3.23
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 51.9% year-over-year.
- Ranks #181 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.36 | -51.9% |
| FY2024 | -$4.19 | +22.3% |
| FY2023 | -$5.39 | -260.9% |
| FY2022 | -$1.49 | -83.7% |
| FY2021 | -$0.81 | +93.4% |
| FY2020 | -$12.25 | +37.2% |
| FY2019 | -$19.52 | -11.3% |
| FY2018 | -$17.54 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026